BB Biotech 2nd Line Ord Shs (BBZA:) – Aktiekurser och nyheter

StartsidaBBZA • FRA

BB Biotech 2nd Line Ord Shs

39,15 €

18 okt., 22:59:47 GMT+2 · EUR · FRA · Ansvarsfriskrivning

AktieVärdepapper listat i DEHuvudkontor i CH

Föregående stängning

39,95 €

Dygnsintervall

39,05 € - 40,20 €

Årsintervall

36,70 € - 52,60 €

Börsvärde

2,07 md CHF

Genomsnittlig volym

3,69 tn

P/E-tal

Direktavkastning

Primär börs

SWX

Ekonominyheter

MSN

för 1 dag sedan

Nya rekord på Wall Street – Netflix draglok

Små rörelser på New York-börsen

The S&P 500 Just Did This for the First Time in 13 Years. Here's What History Says Happens Next.

The relentless stock market rally could pull off another shocker

This Hot Tech Stock Just Knocked Tesla Out Of The S&P 500 Magnificent Seven. Should You Be Buying?

Business Insider

för 18 timmar sedan

Economist Who Called '08 Recession Warns Stocks in 'Mega-Bubble'

.INX

0,40 %

BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange. It is one of the largest investment companies in the biotech sector. Wikipedia

Grundades

9 nov. 1993

Huvudkontor

Küsnacht Zürich
Schweiz

Hemsida

bbbiotech.ch